OCCURRENCE OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B PATIENTS UNDERGOING ENTECAVIR OR TENOFOVIR TREATMENT

被引：0
|
作者：
Lee, Chieh-Ju [1 ]
Su, Chien-Wei [1 ,2 ]
Lin, Han-Chieh [1 ,2 ,3 ]
Hou, Ming-Chih [1 ,2 ,3 ]
Huang, Yi-Hsiang [1 ,2 ,3 ]
机构：
[1] Taipei Vet Gen Hosp, Div Gastroenterol & Hepatol, Dept Med, Taipei, Taiwan
[2] Natl Yang Ming Univ, Fac Med, Sch Med, Taipei, Taiwan
[3] Natl Yang Ming Univ, Inst Clin Med, Taipei, Taiwan
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
944
引用
收藏
页码：578A / 579A
页数：2
相关论文
共 50 条
  • [1] Comparison of Tenofovir and Entecavir in the Prevention of Hepatocellular Carcinoma Occurrence in Patients with Chronic Hepatitis B
    Facciorusso, Antonio
    Cincione, Ivan
    Sacco, Rodolfo
    [J]. LIVER CANCER, 2021, 10 (03) : 285 - 286
  • [2] Occurence of hepatocellular carcinoma in chronic hepatitis B patients undergoing entecavir or tenofovir treatment: a multicenter study in Taiwan
    Huang, Yi-Hsiang
    Yu, Ming-Lung
    Peng, Cheng-Yuan
    Liu, Chun-Jen
    Hung, Chao-Hung
    Cheng, Pin-Nan
    Chen, Jyh-Jou
    Hu, Tsung-Hui
    Lee, ChiehJu
    Chien, Rong-Nan
    [J]. JOURNAL OF HEPATOLOGY, 2020, 73 : S887 - S887
  • [3] Meta-analysis of the occurrence of hepatocellular carcinoma after the treatment of entecavir and tenofovir for chronic hepatitis B
    Tang, Kaiyue
    Cheng, Huizhen
    Wang, Haiyan
    Guo, Yueping
    [J]. MEDICINE, 2023, 102 (06) : E32894
  • [4] Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
    Lee, Han Ah
    Seo, Yeon Seok
    Kim, Seung Up
    [J]. GASTROENTEROLOGY, 2020, 158 (08) : 2310 - 2311
  • [5] Tenofovir treatment has lower risk of hepatocellular carcinoma than entecavir treatment in patients with chronic hepatitis B
    Yip, Terry C. F.
    Wong, Vincent Wai-Sun
    Tse, Yee-Kit
    Chan, Henry
    Wong, Grace Lai-Hung
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E128 - E128
  • [6] Risk of hepatocellular carcinoma with tenofovir versus entecavir in chronic hepatitis B
    Choi, Won-Mook
    Choi, Jonggi
    Wong, Grace Lai-Hung
    Han, Seungbong
    Lim, Young-Suk
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (02): : 87 - 87
  • [7] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Jung Woo Shin
    Joonho Jeong
    Seok Won Jung
    Seung Bum Lee
    Bo Ryung Park
    Min-Ju Kim
    Eun Ji Park
    Neung Hwa Park
    [J]. Digestive Diseases and Sciences, 2021, 66 : 1739 - 1750
  • [8] Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir
    Shin, Jung Woo
    Jeong, Joonho
    Jung, Seok Won
    Lee, Seung Bum
    Park, Bo Ryung
    Kim, Min-Ju
    Park, Eun Ji
    Park, Neung Hwa
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (05) : 1739 - 1750
  • [9] Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
    Zhang, Hao
    Zeng, Wenting
    [J]. JAMA ONCOLOGY, 2019, 5 (06) : 914 - 915
  • [10] Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B
    Kamal, Faisal
    Khan, Muhammad Ali
    Ahmed, Aijaz
    Nair, Satheesh
    [J]. GUT, 2020, 69 (11) : 2054 - +
12345